← Leaderboards
Xiangdong William Yang
University Of California Los Angeles
$28,254,046
Attributed
$41,317,307
Total exposure
16
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$41,317,307 · 16
By mechanism
U01$17,812,075 · 3
R01$11,017,364 · 5
RF1$8,414,427 · 2
P50$2,988,394 · 2
R61$719,114 · 2
R21$355,933 · 1
Top collaborators
- Hong-Wei Dong10 shared
- Beth Ann Stevens6 shared
- Bruce T Lamb4 shared
- Anjie Zhen1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Hong-Wei Dong$37,872,496
- Giovanni Coppola$6,186,082
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsCellsGeneticCorpus Striatum StructureMolecularMouse ModelBrainBaseIn VivoCell TypeHuntington DiseaseMutantProteinsGenesPathogenesisNeurodegenerative DisordersBehavioralPathway InteractionsPolyglutamineResponseHippocampal Pyramidal NeuronMediatingLengthTransgenic Mice
Grant awards (62)
Mapping Cellular Resolution Connectopathies in Aging and Alzheimer's Disease$2,815,466
U01 · FY2025 · AG
Hematopoietic Stem Cell-based CAR Macrophage for Alzheimer's Disease$374,000
R61 · FY2025 · AG
High-throughput small molecule screen to reduce endogenous level of Msh3 for disease-modifying HD therapy$345,114
R61 · FY2025 · NS · contact PI
2025 CAG Triplet Repeat Disorders Gordon Research Conference and Gordon Research Seminar$10,000
R13 · FY2025 · NS · contact PI
Mapping Cellular Resolution Connectopathies in Aging and Alzheimer's Disease$2,918,576
U01 · FY2024 · AG
Mapping Cellular Resolution Connectopathies in Aging and Alzheimer's Disease$2,888,439
U01 · FY2023 · AG
Novel mouse genetic models to study modifiers of Huntingtonâs disease$642,984
R01 · FY2023 · NS · contact PI
Mapping Cellular Resolution Connectopathies in Aging and Alzheimer's Disease$2,874,982
U01 · FY2022 · AG
Dendritome mapping of genetically-defined and sparsely-labeled cortical and striatal projection neurons$837,445
U01 · FY2022 · MH · contact PI
Novel mouse genetic models to study modifiers of Huntingtonâs disease$642,984
R01 · FY2022 · NS · contact PI
Next-generation MORF Mice for Scalable Brainwide Morphological Mapping and Genetic Perturbation of Single Neurons$4,353,658
RF1 · FY2021 · MH · contact PI
Dendritome mapping of genetically-defined and sparsely-labeled cortical and striatal projection neurons$853,045
U01 · FY2021 · MH · contact PI
Novel mouse genetic models to study modifiers of Huntingtonâs disease$642,984
R01 · FY2021 · NS · contact PI
Genetic Dissection of Striatal Indirect-Pathway in Opioid Withdrawal Aversion$326,263
P50 · FY2021 · DA · contact PI
Technical Advancement Core$267,995
P50 · FY2021 · DA · contact PI
Dendritome mapping of genetically-defined and sparsely-labeled cortical and striatal projection neurons$853,045
U01 · FY2020 · MH · contact PI
Novel mouse genetic models to study modifiers of Huntingtonâs disease$642,984
R01 · FY2020 · NS · contact PI
Genetic Dissection of Striatal Indirect-Pathway in Opioid Withdrawal Aversion$327,319
P50 · FY2020 · DA · contact PI
Technical Advancement Core$267,996
P50 · FY2020 · DA · contact PI
Dendritome mapping of genetically-defined and sparsely-labeled cortical and striatal projection neurons$841,635
U01 · FY2019 · MH · contact PI
Novel mouse genetic models to study modifiers of Huntingtonâs disease$641,564
R01 · FY2019 · NS · contact PI
Genetic Dissection of Striatal Indirect-Pathway in Opioid Withdrawal Aversion$327,670
P50 · FY2019 · DA · contact PI
Technical Advancement Core$267,996
P50 · FY2019 · DA · contact PI
Dendritome mapping of genetically-defined and sparsely-labeled cortical and striatal projection neurons$892,381
U01 · FY2018 · MH · contact PI
Complement-Microglia Interaction in Synaptic Loss and Neurodegeneration in HD$352,273
R01 · FY2018 · NS · contact PI
Genetic Dissection of Striatal Indirect-Pathway in Opioid Withdrawal Aversion$327,118
P50 · FY2018 · DA · contact PI
Technical Advancement Core$267,995
P50 · FY2018 · DA · contact PI
BAC Transgenic Mouse Models of TREM2 to Study Neuroprotective Mechanisms in AD$4,060,769
RF1 · FY2017 · AG · contact PI
Complement-Microglia Interaction in Synaptic Loss and Neurodegeneration in HD$352,273
R01 · FY2017 · NS · contact PI
Genetic Dissection of Striatal Indirect-Pathway in Opioid Withdrawal Aversion$327,255
P50 · FY2017 · DA · contact PI
Technical Advancement Core$280,787
P50 · FY2017 · DA · contact PI
Novel Genetic Strategy for Sparse Labeling and Manipulation of Mammalian Neurons$663,196
U01 · FY2016 · MH · contact PI
Complement-Microglia Interaction in Synaptic Loss and Neurodegeneration in HD$353,543
R01 · FY2016 · NS · contact PI
Novel Genetic Strategy for Sparse Labeling and Manipulation of Mammalian Neurons$689,376
U01 · FY2015 · MH · contact PI
Complement-Microglia Interaction in Synaptic Loss and Neurodegeneration in HD$347,074
R01 · FY2015 · NS · contact PI
Novel Genetic Strategy for Sparse Labeling and Manipulation of Mammalian Neurons$92,400
U01 · FY2015 · MH · contact PI
Complement-Microglia Interaction in Synaptic Loss and Neurodegeneration in HD$50,000
R01 · FY2015 · NS · contact PI
Novel Genetic Strategy for Sparse Labeling and Manipulation of Mammalian Neurons$592,089
U01 · FY2014 · MH · contact PI
Complement-Microglia Interaction in Synaptic Loss and Neurodegeneration in HD$336,200
R01 · FY2014 · NS · contact PI
Validating NT17 Dependent Mechanisms in Huntington's Disease Suppression$333,507
R01 · FY2014 · NS · contact PI
Conditional Models: non-cell-autonomous Toxicities in HD$326,836
R01 · FY2014 · NS · contact PI
Validating NT17 Dependent Mechanisms in Huntington's Disease Suppression$325,085
R01 · FY2013 · NS · contact PI
Conditional Models: non-cell-autonomous Toxicities in HD$318,583
R01 · FY2013 · NS · contact PI
Validating NT17 Dependent Mechanisms in Huntington's Disease Suppression$63,999
R01 · FY2013 · NS · contact PI
Validating NT17 Dependent Mechanisms in Huntington's Disease Suppression$336,875
R01 · FY2012 · NS · contact PI
Conditional Models: non-cell-autonomous Toxicities in HD$330,138
R01 · FY2012 · NS · contact PI
Validating NT17 Dependent Mechanisms in Huntington's Disease Suppression$50,000
R01 · FY2012 · NS · contact PI
Validating NT17 Dependent Mechanisms in Huntington's Disease Suppression$336,875
R01 · FY2011 · NS · contact PI
Conditional Models: non-cell-autonomous Toxicities in HD$330,138
R01 · FY2011 · NS · contact PI
Conditional Models: non-cell-autonomous Toxicities in HD$228,138
R01 · FY2011 · NS · contact PI
Basal Ganglia Circuitry and Molecules in Pathogenesis of Motor Stereotypy$387,767
R01 · FY2010 · HD · contact PI
Conditional Models: non-cell-autonomous Toxicities in HD$336,875
R01 · FY2010 · NS · contact PI
Conditional Models: non-cell-autonomous Toxicities in HD$77,000
R01 · FY2010 · NS · contact PI
Basal Ganglia Circuitry and Molecules in Pathogenesis of Motor Stereotypy$419,799
R01 · FY2009 · HD · contact PI
Conditional Mouse Models: Non-cell-antonomous Toxicities in Huntington's Disease$72,406
R01 · FY2009 · NS · contact PI
Conditional Mouse Models: Non-cell-antonomous Toxicities in Huntington's Disease$338,768
R01 · FY2008 · NS · contact PI
Conditional Mouse Models: Non-cell-antonomous Toxicities in Huntington's Disease$338,768
R01 · FY2007 · NS · contact PI
Conditional Models: Non-cell-antonomous Toxicities in HD$348,886
R01 · FY2006 · NS · contact PI
Conditional Models: Non-cell-antonomous Toxicities in HD$357,089
R01 · FY2005 · NS
Genetic Suppressors of Huntington's Disease in Mice$178,545
R21 · FY2005 · NS
Conditional Models: Non-cell-autonomous Toxicities in HD$354,969
R01 · FY2004 · NS
Genetic Suppressors of Huntington's Disease in Mice$177,388
R21 · FY2004 · NS